| Donna Jane Dassel-stuke, | |
|
8325 Lenexa Dr Ste 150, Lenexa, KS 66214-1654 | |
| (913) 652-9229 | |
| Not Available |
| Full Name | Donna Jane Dassel-stuke |
|---|---|
| Gender | Female |
| Speciality | Psychologist - School |
| Location | 8325 Lenexa Dr Ste 150, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225551872 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TS0200X | Psychologist - School | 89336395211 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donna Jane Dassel-stuke, Po Box 151, Bern, KS 66408-0151 Ph: () - | Donna Jane Dassel-stuke, 8325 Lenexa Dr Ste 150, Lenexa, KS 66214-1654 Ph: (913) 652-9229 |
News Archive
Stroke and other diseases and injuries to the brain are often followed by inflammation, caused by a reaction of the body's immune system. This reaction has been seen as something that must be combated, but perhaps the immune system could in fact help with recovery following a stroke. A major new EU project, led by Lund University in Sweden and the Weizmann Institute in Israel, is going to study this question.
An infrequently used blood test can effectively identify individuals at increased risk of developing complications associated with chronic kidney disease (CKD), according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).
Researchers at NYU Langone Medical Center and elsewhere say that a vaccination they have developed to fight a brain-based, wasting syndrome among deer and other animals may hold promise on two additional fronts: Protecting U.S. livestock from contracting the disease, and preventing similar brain infections in humans.
Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.
Arrowhead Research Corporation, a targeted therapeutics company, today announced that its hepatitis B virus (HBV) program has completed all internal preclinical requirements and has named a clinical candidate.
› Verified 5 days ago
Marc A Schlosberg, PH D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Jimmie Gene Lemons, ED.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 15700 College Blvd, Suite 201, Lenexa, KS 66219 Phone: 913-383-8977 Fax: 913-383-3116 | |
Douglas Hippe, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 12805 W 100th Ter, Lenexa, KS 66215 Phone: 913-271-7899 Fax: 913-894-1329 | |
Ms. Alexandria L Kaplan, LMLP-T Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St Ste 100, Lenexa, KS 66214 Phone: 913-677-3553 | |
Ms. Cassandra Ann Thompson, LMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 100, Lenexa, KS 66214 Phone: 913-677-3553 Fax: 913-677-3282 | |
Bambi Burgard, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8629 Bluejacket St, Suite 102, Lenexa, KS 66214 Phone: 913-677-0500 Fax: 913-677-5243 |